{
    "2020-01-21": [
        [
            {
                "time": "",
                "original_text": "肺 癌 靶 向 药 销 售 持 续 放 量  贝 达 药 业 去 年 净 利 预 增 两 成 以 上",
                "features": {
                    "keywords": [
                        "靶向药",
                        "销售放量",
                        "贝达药业",
                        "净利预增"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "无 产 品 无 收 入 无 利 润  泽 璟 制 药 拟 发 3 3 . 7 6 元 谁 博 傻 接 盘 ？",
                "features": {
                    "keywords": [
                        "泽璟制药",
                        "无产品",
                        "无收入",
                        "拟发行价"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "2 3 公 司 获 得 增 持 评 级 - 更 新 中",
                "features": {
                    "keywords": [
                        "增持评级",
                        "公司数量"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【 天 风 医 药 】 贝 达 药 业 ： 埃 克 替 尼 持 续 放 量 ， 管 线 梯 队 不 断 充 实",
                "features": {
                    "keywords": [
                        "天风医药",
                        "贝达药业",
                        "埃克替尼",
                        "持续放量",
                        "管线梯队充实"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}